EUVIMEDEUVIMED entdecken
Crossref

Contemporary methods of risk assessment and novel treatment options for very high-risk patients in primary cardiovascular prevention: focus on finerenone

Leonid L. Bershtein, Elizaveta V. Zbyshevskaya, Victoria E. Gumerova

HERALD of North-Western State Medical University named after I.I. Mechnikov · 30.03.2026 · 18 (1) · 5-13

DOI: 10.17816/mechnikov690537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HERALD of North-Western State Medical University named after I.I. Mechnikov, online erschienen am 30.03.2026. Verfasst von Leonid L. Bershtein und 2 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the high medical and social significance of atherosclerotic cardiovascular diseases (ASCVD), great attention is paid to improving approaches to their primary prevention. This article discusses new approaches to assessing the risk of cardiovascular diseases and their prevention. Considerable focus has been placed on the use of the SCORE2 scale, developed on the basis of current data on morbidity and mortality from cardiovascular diseases in Europe and accounting for both fatal and nonfatal cardiovascular events as outcomes. Ways to refine risk using clinical and laboratory risk modifiers are discussed. Also considered is the introduction into clinical practice of instrumental methods, including assessment of the coronary artery calcium score and ultrasound analysis of carotid artery atherosclerotic plaque, which allows for refinement of the probability of events in intermediate-risk patients. The place of these techniques in current clinical guidelines is discussed, as well as the potential of CT coronary angiography in primary cardiovascular prevention. The presented data will help cardiologists and general practitioners to correctly assess risk in practice in individuals without clinical signs of ASCVD. A separate section is devoted to the assessment of cardiovascular risk in type 2 diabetes mellitus (T2DM) and chronic kidney disease. These are special patient categories in which cardiovascular risk is generally high or very high. Therefore, risk calculation using risk scores is not performed in these patients. The mechanisms of the influence of T2DM and chronic kidney disease on atherogenesis, endothelial dysfunction, and the development of heart failure are discussed. Current concepts of the pathogenesis and therapeutic approaches for a special very high-risk condition, diabetic nephropathy, are highlighted, with an emphasis on the role of the new third-generation selective nonsteroidal mineralocorticoid receptor antagonist, finerenone. Attention to it is driven by the fact that it is the first drug of this class to be used in the primary prevention of ASCVD. The results of large randomized clinical trials are presented, which confirmed its efficacy in reducing cardiovascular and renal outcomes in patients with T2DM and albuminuric diabetic nephropathy, predominantly without established ASCVD. Thus, the article familiarizes the reader with updated algorithms for the primary prevention of ASCVD. Particular attention is paid to very high-risk patients due to T2DM and chronic kidney disease, and to the role of the new selective mineralocorticoid receptor inhibitor, finerenone, in their treatment.

Zitieren

APA

Bershtein, L. L., Zbyshevskaya, E. V., & Gumerova, V. E. (2026). Contemporary methods of risk assessment and novel treatment options for very high-risk patients in primary cardiovascular prevention: focus on finerenone. HERALD of North-Western State Medical University named after I.I. Mechnikov, 18(1), 5-13. https://doi.org/10.17816/mechnikov690537

Vancouver

Bershtein LL, Zbyshevskaya EV, Gumerova VE. Contemporary methods of risk assessment and novel treatment options for very high-risk patients in primary cardiovascular prevention: focus on finerenone. HERALD of North-Western State Medical University named after I.I. Mechnikov. 2026;18(1):5-13. doi:10.17816/mechnikov690537

BibTeX
@article{Bershtein2026,
  author = {Bershtein, Leonid L. and Zbyshevskaya, Elizaveta V. and Gumerova, Victoria E.},
  title = {Contemporary methods of risk assessment and novel treatment options for very high-risk patients in primary cardiovascular prevention: focus on finerenone},
  journal = {HERALD of North-Western State Medical University named after I.I. Mechnikov},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {5--13},
  doi = {10.17816/mechnikov690537}
}
Kostenlos starten →